{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:50:26Z","timestamp":1793692226363,"version":"4.5.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jconrel.2024.02.030","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T19:22:12Z","timestamp":1709148132000},"page":"233-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief"],"prefix":"10.1016","volume":"368","author":[{"given":"Mengying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.02.030_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal Neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2022.05.005","article-title":"Roadmap to next-generation cancer vaccines","volume":"347","author":"Zheng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002104","article-title":"Immune checkpoint inhibitor-based strategies for synergistic cancer therapy","volume":"10","author":"He","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd4596","article-title":"Big opportunities for small molecules in immuno-oncology","volume":"14","author":"Adams","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0040","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0050","doi-asserted-by":"crossref","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified drug delivery with light-inducible nanocargoes to enhance cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jconrel.2023.11.058","article-title":"Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death","volume":"365","author":"Liu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt0415-321","article-title":"IDO inhibitors move center stage in immuno-oncology","volume":"33","author":"Sheridan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jconrel.2023.02.040","article-title":"Reactive oxygen species-powered cancer immunotherapy: current status and challenges","volume":"356","author":"He","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121433","article-title":"Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy","volume":"282","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0080","doi-asserted-by":"crossref","first-page":"2205694","DOI":"10.1002\/smll.202205694","article-title":"Cascade immune activation of self-delivery biomedicine for photodynamic immunotherapy against metastatic tumor","volume":"19","author":"Zheng","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0085","doi-asserted-by":"crossref","first-page":"2104223","DOI":"10.1002\/adma.202104223","article-title":"Manipulating intratumoral Fenton chemistry for enhanced chemodynamic and chemodynamic-synergized multimodal therapy","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40820-019-0347-0","article-title":"Recent advances in tumor microenvironment hydrogen peroxide-responsive materials for cancer photodynamic therapy","volume":"12","author":"Yang","year":"2020","journal-title":"Nano-Micro Letters"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jconrel.2022.09.003","article-title":"Research Progress on tumor hypoxia-associative nanomedicine","volume":"350","author":"Xu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0105","first-page":"83","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia (Auckland, N.Z.)"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0110","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100787","article-title":"Hypoxia as a driver of resistance to immunotherapy","volume":"59","author":"Kopecka","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0120","doi-asserted-by":"crossref","first-page":"R1072","DOI":"10.1152\/ajpregu.00209.2018","article-title":"Bridging angiogenesis and immune evasion in the hypoxic tumor microenvironment","volume":"315","author":"Schito","year":"2018","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s40169-019-0226-9","article-title":"Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma","volume":"8","author":"Daniel","year":"2019","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0130","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/cells9040992","article-title":"Hypoxia-driven immune escape in the tumor microenvironment","volume":"9","author":"Vito","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0135","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0140","doi-asserted-by":"crossref","first-page":"2100233","DOI":"10.1002\/advs.202100233","article-title":"Hyperbaric oxygen boosts PD-1 antibody delivery and T cell infiltration for augmented immune responses against solid tumors","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0145","first-page":"9","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia, cancer","volume":"5","author":"Scharping","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-013-0041-3","article-title":"Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy","volume":"15","author":"Ding","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0155","doi-asserted-by":"crossref","first-page":"1900321","DOI":"10.1002\/adma.201900321","article-title":"Near-infrared-II molecular dyes for cancer imaging and surgery","volume":"31","author":"Zhu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0160","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1038\/s41467-020-19945-w","article-title":"Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122257","article-title":"Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy","volume":"301","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2018.03.020","article-title":"IR780 based nanomaterials for cancer imaging and photothermal, photodynamic and combinatorial therapies","volume":"542","author":"Alves","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0175","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1021\/acs.nanolett.3c01914","article-title":"Steerable microneedles enabling deep delivery of photosensitizers and CRISPR\/Cas9 systems for effective combination cancer therapy","volume":"23","author":"Wang","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0180","article-title":"Dually enhanced phototherapy by Gambogic acid and Hyperthemia-activated chemotherapy for synergistic breast cancer treatment","volume":"452","author":"Wang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0185","doi-asserted-by":"crossref","first-page":"1603440","DOI":"10.1002\/adfm.201603440","article-title":"Mimicking drug\u2013substrate interaction: a smart bioinspired technology for the fabrication of theranostic nanoprobes","volume":"27","author":"Pan","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0190","doi-asserted-by":"crossref","first-page":"1904639","DOI":"10.1002\/adma.201904639","article-title":"Intra\/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors","volume":"31","author":"Gao","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0195","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/acsnano.7b08219","article-title":"Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic\/chemotherapy","volume":"12","author":"Pei","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2020.02.043","article-title":"Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer","volume":"321","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0205","doi-asserted-by":"crossref","first-page":"1906805","DOI":"10.1002\/adfm.201906805","article-title":"Phase-change materials based nanoparticles for controlled hypoxia modulation and enhanced phototherapy","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jconrel.2020.10.030","article-title":"Serum protein-based nanoparticles for cancer diagnosis and treatment","volume":"329","author":"Iqbal","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom9120789","article-title":"Paclitaxel\u2019s mechanistic and clinical effects on breast cancer","volume":"9","author":"Abu Samaan","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0220","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0225","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1021\/acsnano.8b01893","article-title":"All-in-one Theranostic Nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0235","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell\u2013mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0240","doi-asserted-by":"crossref","first-page":"1906832","DOI":"10.1002\/smll.201906832","article-title":"Codelivery of anti-PD-1 antibody and paclitaxel with matrix metalloproteinase and pH dual-sensitive micelles for enhanced tumor chemoimmunotherapy","volume":"16","author":"Su","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0245","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41368-022-00203-2","article-title":"The role of dendritic cells in the immunomodulation to implanted biomaterials","volume":"14","author":"Wang","year":"2022","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0255","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jacs.9b12232","article-title":"Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting Indoleamine 2,3-dioxygenase","volume":"142","author":"Han","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0260","doi-asserted-by":"crossref","first-page":"1803001","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0265","doi-asserted-by":"crossref","first-page":"2207951","DOI":"10.1002\/adma.202207951","article-title":"Lactate-oxidase-instructed cancer diagnosis and therapy","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0270","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0275","doi-asserted-by":"crossref","first-page":"1900037","DOI":"10.1002\/advs.201900037","article-title":"Multifunctional nanoregulator reshapes immune microenvironment and enhances immune memory for tumor immunotherapy","volume":"6","author":"Yu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","article-title":"Towards targeting of shared mechanisms of cancer metastasis and therapy resistance","volume":"22","author":"Weiss","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0285","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/anie.201805664","article-title":"Chemodynamic therapy: tumour microenvironment-mediated Fenton and Fenton-like reactions","volume":"58","author":"Tang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120388","article-title":"IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment","volume":"269","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0295","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0300","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0305","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0310","series-title":"Pharmaceutics","author":"Tong","year":"2022"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0315","doi-asserted-by":"crossref","first-page":"2207608","DOI":"10.1002\/advs.202207608","article-title":"Metabolic intervention liposome boosted lung cancer radio-immunotherapy via hypoxia amelioration and PD-L1 restraint","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0320","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jconrel.2022.11.004","article-title":"Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy","volume":"352","author":"Zhou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0325","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0335","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2019.12.042","article-title":"Mesoporous carbon-manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy","volume":"319","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0340","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/pharmaceutics15102480","article-title":"Recent advances of tumor microenvironment-responsive nanomedicines-energized combined phototherapy of cancers","volume":"15","author":"Liu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0345","doi-asserted-by":"crossref","first-page":"1900927","DOI":"10.1002\/adma.201900927","article-title":"Light-triggered in situ gelation to enable robust photodynamic-immunotherapy by repeated stimulations","volume":"31","author":"Meng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0350","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/acsnano.7b00715","article-title":"Near-infrared-triggered photodynamic therapy with multitasking Upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0355","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1021\/acsnano.9b06040","article-title":"Near-infrared II phototherapy induces deep tissue immunogenic cell death and potentiates cancer immunotherapy","volume":"13","author":"Ma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.02.030_bb0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T cell subsets","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41467-020-20243-8","article-title":"Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.02.030_bb0375","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:34:47Z","timestamp":1738082087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":75,"alternative-id":["S0168365924001251"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}